 | Up a level |
2021
Birrer, Dominique L., Golcher, Henriette, Casadei, Riccardo, Haile, Sarah R., Fritsch, Ralph, Hussung, Saskia, Brunner, Thomas B., Fietkau, Rainer, Meyer, Thomas, Gruetzmann, Robert, Merkel, Susanne, Ricci, Claudio 
ORCID: 0000-0002-6638-4479, Ingaldi, Carlo, Di Marco, Mariacristina, Guido, Alessandra, Serra, Carla, Minni, Francesco, Pestalozzi, Bernhard, Petrowsky, Henrik, DeOliveira, Michelle, Bechstein, Wolf O., Bruns, Christiane J., Oberkofler, Christian E., Puhan, Milo, Lesurtel, Mickaeel, Heinrich, Stefan and Clavien, Pierre-Alain
(2021).
Neoadjuvant Therapy for Resectable Pancreatic Cancer A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials.
Ann. Surg., 274 (5).
S. 713 - 721.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1528-1140
Eichler, Martin ORCID: 0000-0001-9654-2207, Pink, Daniel ORCID: 0000-0001-7243-7373, Menge, Franka, Jakob, Jens, Hentschel, Leopold, Richter, Stephan, Hohenberger, Peter, Kasper, Bernd, Andreou, Dimosthenis, Singer, Susanne, Gruetzmann, Robert, Dmytrow, Diana I., Arndt, Karin, Tuchscherer, Armin, Reichardt, Peter, Ahrens, Marit, Kunitz, Annegret, Mohm, Johannes, Bornhaeuser, Martin, Schmitt, Jochen and Schuler, Markus K.
(2021).
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa).
Eur. J. Cancer Care, 30 (6).
HOBOKEN:
WILEY.
ISSN 1365-2354
2017
Sinn, Marianne, Bahra, Marcus, Liersch, Torsten, Gellert, Klaus, Messmann, Helmut, Bechstein, Wolf ORCID: 0000-0002-3267-8145, Waldschmidt, Dirk, Jacobasch, Lutz, Wilhelm, Martin, Rau, Bettina M., Gruetzmann, Robert, Weinmann, Arndt ORCID: 0000-0003-1198-1716, Maschmeyer, Georg, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Stieler, Jens M., Striefler, Jana K., Ghadimi, Michael, Bischoff, Sven, Doerken, Bernd, Oettle, Helmut and Riess, Hanno
(2017).
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial.
J. Clin. Oncol., 35 (29).
S. 3330 - 3341.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755